Company intelligence / Profile preview

Nimble Science

Calgary, Alberta, Canadanimblesci.com ↗
Ownership
Private
Employees
~15
Development stage
Commercial
01

Overview

Nimble Science has developed and commercialized the SIMBA GI Platform—a first-in-class ingestible capsule that autonomously collects, seals, and preserves multiomic fluid biopsies from the small intestine. This enables at-home collection of high-quality samples to generate actionable insights into gut microbiome composition and function. The technology supports pharmaceutical, diagnostic, food/supplement companies in R&D by providing access to previously inaccessible regions of the GI tract. It has been recognized with industry awards such as NutraIngredients-USA Start-up of the Year in 2024. No direct clinical results are reported since it’s a data/diagnostic platform.

Therapeutic areas
Gastroenterology
Modalities
Device (ingestible capsule)Diagnostic platform (multi-omic data collection)Microbial therapy (enabling research and development)Live biotherapeutic product therapy (enabling research and development)
Industry
Consumable Medical Devices
02

Partnerships

Cmbio™ (multiomics science/digital biology partner)NIZO Food Research B.V. (food & health innovation CRO partner)Seqbiome/APC Microbiome spin-out (microbiome testing services partner)

Beyond the preview

Go deeper on Nimble Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nimble Science.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call